67 related articles for article (PubMed ID: 1855201)
1. Lung cancer-associated protein: development and characterization of a new assay that detects a circulating lung cancer marker.
Maimonis P; Hayes DF; Schaffel S; Kufe D
Cancer Res; 1991 Aug; 51(15):3838-42. PubMed ID: 1855201
[TBL] [Abstract][Full Text] [Related]
2. Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93.
Shitara K; Hanai N; Yoshida H
Cancer Res; 1987 Mar; 47(5):1267-72. PubMed ID: 3545444
[TBL] [Abstract][Full Text] [Related]
3. Detection and characterization of a high molecular weight human lung carcinoma-associated glycoprotein.
Maimonis P; Hayes DF; O'Hara C; Kufe D
Cancer Res; 1990 Oct; 50(20):6738-43. PubMed ID: 1698541
[TBL] [Abstract][Full Text] [Related]
4. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells.
Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K
Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184
[TBL] [Abstract][Full Text] [Related]
5. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma.
Kohno N; Akiyama M; Kyoizumi S; Hakoda M; Kobuke K; Yamakido M
Jpn J Clin Oncol; 1988 Sep; 18(3):203-16. PubMed ID: 3411786
[TBL] [Abstract][Full Text] [Related]
6. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
7. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung.
Hanai N; Shitara K; Yoshida H
Cancer Res; 1986 Sep; 46(9):4438-43. PubMed ID: 3731100
[TBL] [Abstract][Full Text] [Related]
8. Detection of a circulating tumor-associated antigen with a murine monoclonal antibody, LISA 101, selected by reversed indirect enzyme-linked immunosorbent assay.
Kohno N; Kyoizumi S; Tanabe M; Oyama T; Vossler M; Yamakido M; Akiyama M
Cancer Res; 1989 Jun; 49(12):3412-9. PubMed ID: 2655895
[TBL] [Abstract][Full Text] [Related]
9. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
Bray KR; Koda JE; Gaur PK
Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
[TBL] [Abstract][Full Text] [Related]
10. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
[TBL] [Abstract][Full Text] [Related]
11. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
12. Detection of the circulating lung cancer marker LCAP with a new monoclonal antibody TRD-L1.
Tsuji K; Uwano T; Yoshida Y; Kikuchi K; Okamoto T; Yamamoto S; Ichiki M; Hayashi I; Ohno T; Kufe DW
Int J Biol Markers; 1997; 12(2):49-54. PubMed ID: 9342632
[TBL] [Abstract][Full Text] [Related]
13. [Using two monoclonal antibodies to detect lung carcinoma associated antigen in the sera of patients with lung cancer by BA-ELISA].
Xue W; Hou J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Feb; 13(1):63-7. PubMed ID: 1652380
[TBL] [Abstract][Full Text] [Related]
14. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine.
Kannagi R; Fukushi Y; Tachikawa T; Noda A; Shin S; Shigeta K; Hiraiwa N; Fukuda Y; Inamoto T; Hakomori S
Cancer Res; 1986 May; 46(5):2619-26. PubMed ID: 3008996
[TBL] [Abstract][Full Text] [Related]
15. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
[TBL] [Abstract][Full Text] [Related]
16. Antigens associated with human squamous cell lung carcinoma defined by murine monoclonal antibodies.
Fernsten PD; Pekny KW; Reisfeld RA; Walker LE
Cancer Res; 1986 Jun; 46(6):2970-7. PubMed ID: 3009005
[TBL] [Abstract][Full Text] [Related]
17. Selection of a monoclonal antibody reactive with a high-molecular-weight glycoprotein circulating in the body fluid of gastrointestinal cancer patients.
Sakurai Y; Hirohashi S; Shimosato Y; Kodaira S; Abe O
Cancer Res; 1988 Jul; 48(14):4053-8. PubMed ID: 2454734
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a malignant phenotype-associated cell surface glycoprotein common to various human tumor cells and preferentially expressed on adenocarcinoma of the lung.
Motté P; Takahashi H; Ozturk M; Wilson BE; Wands JR
Cancer Res; 1989 Mar; 49(6):1349-56. PubMed ID: 2924292
[TBL] [Abstract][Full Text] [Related]
19. Two murine monoclonal antibodies against human lung cancer-associated antigens.
Endo K; Kamma H; Ogata T
Cancer Res; 1986 Dec; 46(12 Pt 1):6369-73. PubMed ID: 2430695
[TBL] [Abstract][Full Text] [Related]
20. Antigens associated with multidrug resistance in H69AR, a small cell lung cancer cell line.
Mirski SE; Cole SP
Cancer Res; 1989 Oct; 49(20):5719-24. PubMed ID: 2571409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
